Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

By X. Castellsagué, Mireia Díaz, S. de Sanjosé, N. Muñoz, Rolando, Herrero, Silvia Franceschi, R. Peeling, R. Ashley, S. Jennifer and 4 more. Journal of the National Cancer Institute, 2006

707 citations recorded by the source corpus.

Subfields: Epidemiology, Microbiology, Obstetrics and Gynecology

View Paper: https://www.semanticscholar.org/paper/7643c54a605fe26f322a92821cd54a907b0610ba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. A. Moscicki
2. M. Stoler
3. Mark Schiffman
4. E. Burd
5. M. Stanley

In Obstetrics and Gynecology

1. E. Burd

Citations in the corpus

• Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth (2008, background): “100% of cervical adeno- and adenosquamous carcinomas [4,5].”
• American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. (2012, positive): “[89], HPV was detected in 93% of 167 adenocarcinomas of the cervix (including 55 adenosquamous carcinomas).”